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INTRODUCTION  
Otoacoustic emission testing is a simple non-invasive and quick test that can be 
performed to analyse preclinical changes in the outer hair cells of patients. 
Studies suggest that minute sub clinical changes occurring in the outer hair cells’ 
function can be precisely predicted with Otoacoustic emissions. 
Ototoxic compounds cause damage by the generation of reactive oxygen species. 
Snake bites and deliberate ingestion of organophosphate poisons represent an 
accidental exposure of outer hair cells to ototoxic compounds. The ototoxic 
potentials of the snake venom and organophosphate compounds has been well 
documented in studies. By testing the Otoacoustic emission we can estimate the 
outer hair cell function of normal persons after an accidental exposure to these 
ototoxic compounds. It is also stipulated to be the main mechanism for outer hair 
cell damage of the cochlea by organophosphate poisoning as well. Some of the 
snake venoms are neurotoxic which act by depletion of NADPH similar to the 
neurotoxic mechanism of organophosphates. 
Repeated follow up with similar testing may also help us to pick up further 
detoriation of the outer hair cell function. Such testing can be used to study and 
approximately estimate the resilience of outer hair cells to the toxic exposure of 
these compounds and can be thus extrapolated to other compounds which may 
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have potential to cause outer hair cell damage. The implications of such studies 
could be far reaching.  
More over since distortion product Otoacoustic emission starts decreasing even 
before the increase in threshold of hearing becomes clinically apparent, it can 
also help us to predict the future hearing loss and initiate the preventive lifestyle 
changes that may be adopted to limit the outer hair cell damage. 
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AIM 
Organophosphate poisoning and snake bite are among the two leading causes of 
poisoning in India and are known for causing damage to multiple organ systems 
in the body because of their toxic effects. The ototoxic potentials of these 
compounds is as yet unexplored in vivo. This study aims to identify the cochlear 
changes by measuring Distortion Product Otoacoustic Emission in patients with 
deliberate ingestion of organophosphate poisoning and accidental neurotoxic 
snake bite. This study would also help to predict the hearing loss in future in such 
patients and institute early rehabilitative measures. 
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ANATOMY OF INNER EAR 
The inner ear or labyrinth lies in the temporal bone in the petrous part. It consists 
of two portions, a strong bony labyrinth inside of it is  the membranous labyrinth 
these both were usually separated from the bony part by means of fluid 
perilymph. The membranous labyrinth is filled with endolymph. 
BONY LABYRINTH  :- 
It consists of three parts –  
1. anteriorly – cochlea, 
2. vestibule in the middle  
3. posteriorly semi-circular canals 
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COCHLEA 
 
The bony cochlea resembles like a common snail’s shell and it forms the anterior 
part of labyrinth. It has a conical central axis known as modiolus and the cochlear 
canal makes 2 ¾ turns around it. The modulus is directed forwards and laterally 
with its apex pointing towards the medial wall of the middle ear in the antero-
superior direction and the base points towards the fundus of the internal auditory 
meatus. 
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The cochlear canal is partially divided into scala vestibuli above and scala 
tympani below by a spiral ridge of bone termed spiral lamina that projects from 
the modiolus. These relationships apply to the cochlear basal turn. The partition 
between these two passages is usually completed by the basilar membrane. 
Helicotrema is a small opening by which scala vestibuli communicates with scala 
tympani at the apex of cochlea. 
VESTIBULE    
The vestibule lies in the central part of the bony labyrinth. The middle ear lies 
lateral to it and it has an opening in the middle ear at the fenestra vestibuli which 
is closed by the foot plate of stapes.it has three semi-circular canals that open into 
its posterior wall. The medial wall is related to the internal auditory meatus and it 
has elliptical recess behind and spherical recess in front. These two recesses are 
separated by the vestibular crest which splits inferiorly to enclose the cochlear 
recess. Just below the elliptical recess there is the opening of the diverticulum, 
the aqueduct of the vestibule, which opens into a narrow fissure on the posterior 
aspect of the petrous temporal bone postero-lateral to the internal auditory 
meatus. It encloses the ductus endolymphaticus and a vein ensuring no perilymph 
escapes through it. 
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SEMI-CIRCULAR CANAL [SCC] 
There are three bony semi-circular canals:  
1. Anterior or superior semi-circular canal  
2. Posterior semi-circular canal  
3. Horizontal or lateral semi-circular canal. 
Each SCC has two ends. They lie at right angles to each other postero-superior to 
vestibule. Each canal is about 2/3
rd
 of a circle and has dilated portion at one end 
forming the ampulla. These three SCC open into vestibule by means of 5 
openings. The anterior canal lies in a vertical plane usually along the long axis of 
temporal bone petrous part. It is convex upwards and its position is indicated by 
the arcuate eminence present over the surface of temporal bone petrous part. The 
ampulla is usually situated antero-laterally. The superior canal and posterior canal 
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unite at upper end to form crus commune and open into the medial wall of 
vestibule at lower end. The posterior semi-circular canal lies in a vertical plane 
parallel to the temporal bone petrous part. Its convexity is directed backwards and 
its ampulla lies at its lower end. The lateral SCC lies in a horizontal plane with its 
convexity directed posterolaterally and its ampulla lies close to the ampulla of the 
anterior canal anteriorly. LSCC of the both sides of the body lie in the same plane 
whereas the anterior SCC of one side lies in the plane of posterior SCC of the 
other side. 
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MEMBRANOUS LABYRINTH 
 It lies within the bony labyrinth as a continuous closed cavity filled with 
endolymph. Its epithelium is specialized to form receptors for hearing (organ of 
Corti). Static balance is mediated by maculae and kinetic balance is mediated by 
cristae.  
Membranous labyrinth consists of two parts 
1. Spiral duct of cochlea  
2. Utricle and Saccule with maculae  
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DUCT OF COCHLEA OR THE SCALA MEDIA  
It lies in the middle part of the cochlear canal found between the scala tympani 
and scala vestibuli otherwise named as spiral duct. Its floor is formed by basilar 
membrane; roof is formed by Reissner’s membrane, outer wall by the bony wall 
of cochlea. The spiral organ of Corti is supported by the basilar membrane. The 
organ of corti is innervated by the peripheral process of the bipolar cells located 
in the spiral ganglion. The ganglion is located in the spiral canal present within 
the modiolus found at the basal lamina. The saccule is connected to the cochlea 
posteriorly by a narrow duct called the ductus reuniens. The sound waves 
reaching the endolymph through the vestibular membrane make appropriate parts 
of the basilar membrane vibrate and so different parts of organ of corti are 
stimulated by different frequencies of sound. The loudness of the sound is 
determined by the amplitude of vibration. 
OUTER HAIR CELLS  
In the human outer hair cells active vibrations within the cell body are triggered 
by the action potentials. Somatic electro-motility is nothing but a mechanical 
response to electrical signals which mainly drives oscillations within the length of 
cell occurring at the frequency of incoming sound and provides amplification of 
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mechanical feedback. Mammals only have outer hair cells. OHC has highly 
improved frequency selectivity for hearing speech and music.  
Non-linear amplification of quiet sound higher than the large ones is the main 
effect of this system. For this property they are also termed as cochlear amplifier. 
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In recent years there is a considerable progression in the molecular biology of 
outer hair cells. Prestin, a protein found in the outer hair cells was found to be 
compromised by marine pesticides. 
 
Stereo-ciliary bundle found at the apex of outer hair cells is the sensory end 
whereas the synaptic pole is found at the base where the afferent and efferent 
nerve fibres usually connect. If they are viewed from above below the apical 
surface is found to be flattened mainly triangular or heart shaped whereas the cell 
bodies are found to be cylindrical.  The arrangements of stereocilia are in the 
form of either “W” or “V” shape, in humans there are about 5 rows. As we go 
about the rows there is an increase in height across the bundle similar to a 
staircase. The basilar membrane stretches from the spiral prominence to the 
osseous spiral lamina. Nerve fibres usually seek its entry through the osseous 
spiral lamina. All the above said structures mainly contribute to the changes that 
systematically occur in the organ of Corti- basilar membrane complex.  
 
 
 
Innervation of organ of corti  
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The auditory portion of the vestibulocochlear nerve is mainly responsible for 
transferring the acoustic information to the ipsilateral cochlear nucleus complex 
in the brainstem from the hair cells where it originated. The cell bodies of spiral 
ganglion along the organ of Corti reside within the modiolus; the auditory nerve 
is composed of afferent fibres which are nothing but the projections from neurons 
of spiral ganglion.  
These spiral ganglion neurons are usually of two types. The inner hair cells are 
innervated by type 1 cells whereas the outer hair cells are innervated by the type 
2 cells. The above said outer hair cells and inner hair cells innervated by these 
two type of nerve fibres have a considerable amount of variation in their 
innervation corresponding to their number and its distribution of fibres. 
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PHYSIOLOGY OF INNER EAR 
COCHLEA  
It is a coiled structure like the shell of a snail. It has two parts 
1. Central conical axis formed by spongy bone called modiolus 
2. Bony canal which winds around the modiolus. 
 
“The cochlea is a system of coiled tubes consisting of three tubes coiled side by 
side, scala vestibuli, scala media, and scala tympani. The scala vestibuli and acala 
media are separated from each other by the Reissner’s membrane. The scala 
vestibuli and scala tympani are separated by basilar membrane. The organ of corti 
is situated in the basilar membrane and it comprises of cells which are usually 
sensitive both electrically and mechanically, arranged in series. They usually 
produces response to sound vibrations as they are end organs of reception.                   
Sound vibrations entering though the scala vestibuli through the oval window 
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from the foot plate of stapes. The oval window is usually closed by the stapes 
foot plate and by means of a ring like ligament that is loosely attached to the 
edge. By this it responds to sound vibrations to and fro. Inward motion of stapes  
causes the perilymph to move along the scala media and vestibuli forward and 
vice versa”. 
Basilar membrane  
 “It is a usually a membrane that is fibrous in nature which separate the scala 
tympani and scala media. The membrane comprises of about thirty thousand 
basilar fibres that are projecting from cochlear bony surface.  . These fibres are 
usually stiff elastic in nature and they are attached to bony cochlea at their base 
but their other ends are mobile and are buried in the basilar membrane.”  
“The lengths of the basilar fibres progressively increase at the level of the oval 
window from the basal turn of the cochlea to the apical region. Their size varies 
starting at a size of 0.04 mm near the oval window and round window to 0.5 mm 
at the tip of the cochlea, which is about 12 fold increase in length”. 
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“The fibre’s thickness normally shows a decreasing pattern from the oval window 
to the Helicotrema. So their thickness shows a reduction larger than hundred fold. 
So by this the short fibres that are usually stiff and found near the oval window 
found to vibrate best with high frequencies whereas the fibres at the cochlear tip 
which are comparatively longer vibrate well at low frequencies.  
In the basilar membrane the resonance for high frequency is found to occur at the 
base where the oval window of the cochlea allows the sound waves. In 
Helicotrema the resonance for the low frequency sound seems to occur due to its 
reduced fibres and also due to high loading with fluid which vibrates along the 
tubules of cochlea”. 
17 
 
“TRANSMISSION OF SOUND WAVES IN THE COCHLEA -Travelling 
wave” 
“The cochlea is usually surrounded on all its sides by bony walls. The round 
window usually projects forwards, when the stapes foot plate moves into the oval 
window. Due to entry of sound wave, it initially causes the basilar membrane 
found at the cochlear base to move towards the round window. Due to the above 
movement, an elastic tension is found to develop in basilar membrane as they 
move along the round window which makes a fluid wave that travels to 
Helicotrema.  By this effect a wave movement is found to occur along the basilar 
membrane that is compared to the wave travelling along a pond surface.  
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Physiology  
The sound waves which have been collected in the outer ear produces vibrations 
in the tympanic membrane. So the pressure in the tympanic membrane is 
increased which is frequency sensitive. This in turn vibrates the middle ear 
ossicles. A highly efficient impedance transformer will change the high 
displacement low pressure vibration into low displacement high pressure 
vibration which is suitable for movement of cochlear fluids. The vibrations 
perceived in the stapes foot plate transmit the mechanical energy derived from the 
ossicular chain through the oval window of the cochlea, thereby delivering 
effectively the sound pressure wave to the scala vestibuli and propagating the 
mechanical motion into pressure waves that will be transmitted through the 
cochlear fluids in a compressible chamber at a velocity of approximately 1.5 
kilometres per second. The scala vestibuli has a high pressure compared to scala 
tympani, producing a difference in pressure across the partition of cochlea, 
thereby creating intra-cochlear forces that are set in motion. The thickness of the 
basilar membrane increases from apex to base where as the thickness and 
composition of filaments decreases from base to apex. The high frequency 
acoustics are selectively transduced at the base of the cochlea because it is stiff. 
The low frequency acoustics are transduced at the apex. 
19 
 
 
The outer hair cells of the cochlea play an important role in the mechanics of 
cochlea actively which mainly uses the biological energy to amplify the basilar 
membrane mechanical vibration which has been sharply tuned for the frequency 
selectivity. The basilar membrane displacement results in a shearing motion 
between the tectorial membrane and the reticular lamina which serves as a 
triggering agent for transudation currents. This shearing motion causes the 
stereocilia to bend in the modiolus direction or in the direction of spiral limbus 
depending on the displacement of basilar membrane. The mechanical stimulus to 
inner hair cells of cochlea causes the stereocilia to move along the flow of 
endolymph in the subcortical space. During the contraction of outer hair cells the 
reticular lamina and the tectorial membrane are pulled together there by 
enhancing the displacement of the basilar membrane during active mechanics. 
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The displacement of basilar membrane varies in radial dimension both in 
magnitude and in phase. The tectorial membrane required for outer hair cells to 
amplify the displacement of the basilar membrane at low frequency levels. 
Transduction by hair cells  
The apical surface of outer hair cells contains stereocilia which are rigid 
mechanically mainly due to the presence of actin filaments in it.  
  
“Their upper surface usually is covered with inter –links and so they move as  
one entity. Stereocilia are usually turned in the direction of stereo cilia which are 
usually taller, which causes stretching at their tip links that leads to opening of 
ion channels in the membrane, whereas if it occurs vice versa the opposite effect 
occurs. Thereby the stimulus is coupled to the transducer channels by means of 
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tip links. The endolymph covering the apex of hair cell has a positive potential of 
eighty five mV. But a negative potential of seventy mV is present inside the cell. 
So when a drop in potential occurs, it increases the positivity in the cell. 
Potassium ions play the major role in the process. Energy for the whole of above 
process is derived from stria vascularis”. 
  
Organ of corti  
It is a neuro-epithelial structure in cochlea and is the receptor organ for hearing. 
Situation and extent   
It rests upon the lip of the osseous spiral lamina and basilar membrane and 
extends throughout the cochlear duct except for a short distance on either end. 
The roof of the organ of corti is formed by gelatinous tectorial membrane. 
Structure  
Organ of corti is made of sensory elements called hair cells and various 
supporting cells. All cells of organ of corti are arranged in order from centre 
towards the periphery of cochlea. 
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Cells of the organ of corti  
1. Border cells  
2. Inner hair cells 
3. Inner phalangeal cells  
4. Inner pillar cells  
5. Outer pillar cells  
6. Outer phalangeal cells  
7. Outer hair cells  
8. Cells of Hensen  
9. Cells of Claudius and Lamina reticularis. 
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Excitation of hair cells  
Steriocilia of hair cells of organ of corti are embedded in tectorial membrane. 
Hair cells are tightly fixed by cuticular lamina reticularis and pillar cells and rods 
of corti. 
When travelling waves causes vibration of basilar membrane at the resonance 
point, the basilar fibres, the rods of corti, the hair cells and the lamina reticularis 
move as a single unit. It causes movement of steriocilia leading to excitement of 
hair cells and generation of receptor potentials. 
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Electrical events during the process of hearing  
It is a type of sensory transduction in the hair cells by which sound energy is 
converted into action potential in the auditory nerve fibre. Three types of action 
potential occur during sound transduction: 
1. Receptor potential or the Cochlear micro phonic  potential 
2. Endo-cochlear potential or Endo-lymphatic potential  
3. Action potential in the auditory nerve fibre 
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Cochlear micro phonic potential  
It is a mild depolarization that is developed when sound waves are transmitted to 
inner ear. Resting membrane potential in hair cells is -60 millivolt. Probable 
neurotransmitter may be glutamate. Movement of steriocilia causes 
depolarization whereas its movement in opposite direction causes 
hyperpolarization. 
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Hair cells  
There are mainly two types of hair cells  
1. Outer hair cells 
2. Inner hair cells  
Outer hair cells  
“The outer hair cells are shortened during depolarization and elongated during 
hyperpolarization. This process is called as electro-motility or mechano-electrical 
transduction. This action facilitates the movement of basilar membrane and 
increases the amplitude and sharpness of sound. Hence the outer hair cells are 
also called collectively as the cochlear amplifier. the electro-motility of hair cells 
is due to the presence of a contractile protein in it, prestin”. 
“The Outer hair cells are usually situated in the basilar membrane of the organ of 
corti. They are usually motile and a motor response is elicited by electrochemical 
response. The outer hair cells have stereo cilia arranged in three rows in a pattern 
of W. These stereocilia move as a single unit as they are linked together. 
Otoacoustic emissions are thought to originate from the outer hair cells”. 
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Inner hair cells  
They are responsible for sound transduction. These are primary sensory cells that 
generate action potential in the nerve fibre. 
Otoacoustic emissions (OAE) 
“Otoacoustic emissions are sounds generated within the normal cochlea either 
spontaneously or in response to acoustic stimulations. OAEs are now thought to 
reflect the activity of active biologic mechanisms within the cochlea responsible 
for its sensitivity, sharp frequency selectivity and wide dynamic range of normal 
auditory system. There is significant indirect evidence that this mechanism is due 
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to the function of outer hair cells in the mammalian cochlea. Also absence of 
Outer hair cells is associated with lack of OAEs supporting the hypothesis that 
the outer hair cells are responsible for generation of OAEs”.  
Properties  
 OAEs are independent of synaptic transmission and are pre-neural. 
 OAEs are unaffected by stimulus rate.  
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 Evoked OAEs are frequency dispersive 
 OAE tuning or suppression curves are very similar to VIII nerve tuning 
curves. 
 OAEs are vulnerable to noxious agents such as ototoxic drugs, 
neurotoxins like snake venom, organophosphates, and hypoxia. 
 It is an objective non-invasive measure of cochlear status in clinical 
population 
“The main objective of Otoacoustic emissions test is to evaluate the condition of 
cochlea, mainly the function of hair cells. OAE testing can be done even in 
patients who are unconscious or those who are in sleep because it does not need 
any behavioural response from the subject”. 
“Cochlea usually produces sounds of low intensity termed Otoacoustic emissions. 
These sounds are found to originate due to the contraction and expansion of outer  
hair cells”.  
There are four types of OAEs which are as follows: 
1. Spontaneous Otoacoustic emissions 
2. Transient evoked Otoacoustic emissions  
3. Distortion product Otoacoustic emissions 
4. Sustained frequency Otoacoustic emissions 
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 “PTA usually evaluates external ear, middle ear, inner ear, vestibulocochlear 
nerve and auditory system. However the emissions arise from cochlea, the outer 
and the middle ear need to be in good function for conduction of emitted sounds 
back to the microphone.  So the status of the cochlear function is measured by the 
OAE testing and it is also used as a screening tool.  However the auditory status 
of a person cannot be fully ascribed by Otoacoustic emissions. But they can help 
by providing information regarding the region of lesion”.  
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RECORDING  
 
“The probe of the machine is placed in the EAC for the purpose of seal. Various 
sized probes are available for children and adults due to their external auditory 
canal volume difference. Sound pressure level will be more effective when it is 
placed in smaller ear canal. 
Many responses are noted and calibrated. The results need to be interpreted in 
comparison to noise floor. Hence for a good recording, minimal ambient noise 
and physiological noise is very important. All OAEs are analyzed relative to 
noise floor. Therefore reduction of physiologic and acoustic ambient noise is 
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critical for good recording. Since no response from the subject is needed, 
Otoacoustic emissions can be measured in unconscious patients”.  
 
Spontaneous Otoacoustic Emissions 
“They are usually spontaneous ones and not in response to any stimulus. They are 
measured in outer ear. Since stimulus is not needed, many recordings can be 
obtained from a single patient to confirm its replicability and also to differentiate 
them from noise floor. These values usually range from five hundred to seven 
thousand  hertz”.  
“These are usually narrow band signals emitted by the ears of humans, even in 
the absecne of acoustic stimulus. These were first identified by Gold in 1948.  
Measurement of SOAEs is relatively simple. In patients with sensory neural 
hearing  loss of grade. Most of the persons are usually un aware of its presence”. 
“They are measured by using a probe placed in the ear canal attached to a low 
noise microphone. All the instruments are caliberated for low noise. Filtration of 
the external noise is of particular importance. They are usually concentrated in 
the range of one to three kilo hertz. Some studeis say the stability of this 
spontaneous acoustic emission will vary and the variability was found in their 
amplitude and frequency within them and sometimes across the session of 
recording”. 
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Transient Otoacoustic Emissions 
“For measuring TOAEs stimuli mainly used are the clicks, sometimes tone 
bursts. The SPL stimuli ranges from eighty to eighty five decibels. The rate of 
stimulation is less than sixty stimuli per second. Recording the TOAES occurs in 
a time span of nearly twenty milliseconds. The responses are measured in two 
separate banks A & B. A Response is one which correlates between the memory 
bank of computers. Noise is one that does not correlate with the same. TAOEs 
usually span the frequency range of five hundred to four thousand hertz”. 
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Distortion product Otoacoustic Emissions 
 
 
“For measuring DPOAEs , stimuli commonly used are two pure tones that are at 
two different frequencies and intensities namely F1, F2 in which F2 value is more 
than F1. The response is mainly elicited by the relationship between the 
frequency and intensity levels. The highest DPOAE usually obtained at F1/ F2 
ratio and it measures about 1.2 for high and low frequency range and for medium 
frequency range it measures about 1.3”. an optimal response is usually obtained if 
l1 equals or is greater than l2. DPOAE will be rendered more prone to errors by 
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lowering of intensities. The commonly used setting is 65/ 55 SPL, l1/l2. 
Responses are recorded in the frequency emission of 2F1-F2. However they are 
more commonly calculated according to F2. this is because F2 corresponds to 
cochlear frequency region in which response is produced.”  
 
 
Prerequisites for obtaining Otoacoustic Emissions 
 Unobstructed outer ear canal 
 Seal of ear canal with the probe 
 Optimal positioning of the probe 
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 Absence of middle ear pathology 
 Functioning cochlear Outer hair cells 
 Relatively quiet recording environment  
 
Spontaneous Otoacoustic Emissions  
“The usual occurrence of spontaneous Otoacoustic emissions in persons range 
from thirty five to forty five per cent in whom hearing is normal. Of these, adult 
population specific range is twenty five to sixty five per cent. But in neonates, 
around twenty to eighty per cent would have these emissions. SOAEs are usually 
absent in persons if their hearing threshold is less than thirty decibel. Hence their 
presence is an index of normal functional cochlea. However, their absence does 
not mean there is a pathology. Spontaneous Otoacoustic emission occur in a 
range of thousand to two thousand hertz, whereas the amplitudes range from -5 to 
15 decibel sound pressure level. Some persons have broader frequency pattern of 
SOAEs. These emissions are usually presence in both ears and rarely lateralized. 
If they lateralize to one ear, right side is more common than the left. In general, 
they are found to be more in females than in males. Association of these 
emissions is rare with tinnitus. Since tinnitus usually occurs in cochlear 
pathology, these emissions are usually absent in this condition. Clinically these 
emissions are used for the purpose of screening of hearing. 
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High level of these emissions sometimes may occur in some individuals, which 
may be heard by others, but these kind of emissions are usually very rare and they 
are more commonly found in children in comparison to adults”. 
 
Transient Otoacoustic Emissions 
“The clinical use of measuring transient Otoacoustic emission is mainly for 
screening of children’s hearing in particular that of infants. It helps to interpret 
the auditory thresholds by validating it electrically and physiologically. Hence it 
helps to assess the location of lesion. These emissions are usually emitted and 
recorded for a transient stimulus. Hence the stimulus has narrow specific 
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frequency range. These emissions usually arise from the broad surface of 
cochlea”. 
 
“Presence of these emissions from a specific frequency range infers the 
sensitivity of the cochlea corresponding to that region is more or less twenty to 
forty decibel. In clinical practice, the presence of these emissions in a specific 
region of the octave band infers that hearing should be thirty decibel hearing loss 
or better”. 
Distortion product Otoacoustic Emissions. 
“The main differentiating feature of TOAEs and DPOAEs is that their higher 
specificity in frequency range which are mainly used for recording high 
frequency range that cannot be done by TOAEs. For these properties, these 
emissions are highly useful in detecting the cochlear pathology as early as 
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possible particularly in oto toxicity and in noise induced hearing loss. The 
reliability of these emissions is very high above 1000 hertz”. 
“For the purpose of screening the hearing of children, especially of infants, both 
distortion product Otoacoustic emissions or transient Otoacoustic emissions are 
used. However transient Otoacoustic emissions have been used for a long time 
for this purpose and are well established. 
Based on the technique used, these emissions are usually recorded in persons 
having hearing loss of mild to moderate degree in whom the transient Otoacoustic  
emissions are found to be absent. These emissions usually correspond to the 
configuration of hearing loss audiometrically”. 
 
Sustained frequency Otoacoustic Emissions 
“These emissions are usually the responses which are produced for a continuous 
tone. Since the emission and the stimulus and its emission superimpose over each 
other in the external ear, the microphone records both the stimulus and its 
emissions. Currently sustained frequency emissions are not practically 
applicable”. 
 
 
40 
 
 
Stimulus Frequency Emissions 
Stimulus frequency emissions are the most frequency specific and probably the 
least clinically applicable of emission types. They reflect the response of the 
cochlea to pure tone input occurring simultaneously with and at the same 
frequency of the eliciting stimulus.  
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When a tone is presented to the ear the sound pressure measured in the ear canal  
is the sum of both the tone presented and the retrograde output of the cochlear 
amplifier, all other types of evoked Otoacoustic emissions have been separated 
from the evoking stimulus either temporally or spectrally. 
 
The lack of temporal / spectral separation requires more sophisticated equipment 
and processing to measure SFEs. They are not currently practical for clinical use. 
To measure SFEs, a tone frequency is presented to the ear through a probe 
microphone assembly system, as in measuring other types of emission. Often the 
tone is swept across a certain frequency range. The SFE is extracted from the 
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recorded ear canal sound pressure by using vector subtraction. This requires a 
lock in amplifier to specify the ear canal sound pressure both in terms of 
amplitude and phase. It also requires that the system of stimulus generation, 
delivery and measurement is liner in both amplitude and phase. 
The SFE is characterized by “dips” and “peaks” indicating the relative strength of 
SFE. The SFE pattern across frequencies is idiosyncratic, that it is unique for 
each ear tested. Certain similarities however can be seen across subjects. In 
general, the frequency separation between adjacent peaks increases with 
increasing frequency. The SFE pattern fattens or loses definition as the evoking 
stimulus increases. SFEs seem to relate closely with auditory sensitivity. 
Specifically comparing auditory threshold microstructure with the SFE pattern 
reveals that threshold minima are found at frequencies where an SFE maxima 
occurs. As with other types of Otoacoustic emissions, SFEs are absent in ears 
with cochlear hearing loss exceeding 40 decibels. 
If the amplitude of tone sweeps is measured by using a spectrum analyser, 
perturbations can be seen at lower levels that are closely related to SFEs. A 
number of reports in the literature have reported such amplitude data as SFEs. 
The phase must also be known. However to perform the vector subtraction, as 
amplitude alone is not sufficient to define the non-linearity or the emission 
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Non pathologic problems that can cause absence of OAEs 
 Poor probe tip placement or poor seal 
 Improper waves 
 Wax in the ear canal. 
 Foreign bodies in the outer ear. 
 Uncooperative patients  
 
Pathologic problems that can cause absence of OAEs 
 External auditory canal atresia. 
 Inflammatory conditions of external ear. 
 Negative pressure in middle ear. 
 Perforation of ear drum 
 Ossicular discontinuity 
 Ossicular sclerosis. 
 Otosclerosis 
 Glue ear. 
 Exposure to ototoxic medications 
 Noise exposure 
 Any other cochlear pathology 
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Conditions that do not affect OAEs 
 Eight cranial nerve pathology 
 Lesions in the higher centers for hearing. 
 Vestibular pathology 
Situations in which there is normal OAEs and unusual behavioural patterns  
 Functional hearing loss 
 Attention deficits  
 Autism 
 Auditory neuropathy 
 Hyperbilirubinemia 
 Neurodegenerative diseases 
 Neurometabolic  diseases 
 Demyelinating diseases. 
 Hereditary motor sensory neuropathology 
 Inflammatory neuropathy  
 Ischemic / hypoxic neuropathy 
 Encephalopathy  
 Meningitis  
 Cerebral palsy 
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Issues in the clinical implementation of Otoacoustic Emissions 
Since OAEs can be measured non-invasively and are sensitive to cochlear status, 
they are potentially a valuable addition to clinical audiology. To optimize the 
clinical utility of OAEs, one needs to decide whether a particular application 
requires knowledge of sensitivity as well as the integrity of the OAE generators. 
 
Finally evoked Otoacoustic Emission should be viewed as an additional objective 
audiological technique and may be most powerful when used in conjunction with 
neural sound evoked potentials and its measurements. Ideally sophisticated 
engineering will allow us to measure external and middle ear impedance 
simultaneously; all types of OAEs, and sound evoked neural potentials.  
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ORGANOPHOSPHATE POISONING 
Every year, nearly one million deaths are due to suicide. Deliberate self -
poisoning has become an increasingly common response in adults due to 
emotional distress. Agricultural pesticides are the substances most commonly 
used for self-poisoning. Among agricultural pesticides the most commonly used 
substances are organophosphate compounds especially in the developing 
countries like India and could potentially affect the hearing due to their 
neurotoxic nature. The principal pharmacological action of all organophospates 
compounds is acetyl cholinesterase inhibition resulting in overstimulation of 
acetyl choline receptors. Most of the studies in animals have been documented 
that these agents have an ototoxic effect and in humans, both peripheral hearing 
loss and central site have been documented to get affected by these compounds. 
Commonly used organophosphorous compounds 
 Ethyl parathion 
 Methyl parathion 
 Monocrotophos 
 Dimethioate 
 Chlorpyriphos 
 Diazinon 
 Methamidaphos 
 Fenthion  
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Mode of action  
 
Organophosphates are powerful inhibitors of acetyl cholinesterase which is 
responsible for hydrolysing acetyl choline to choline and acetic acid after its 
release and completion of function (i.e., propagation of action potential). As a 
result there is accumulation of with continued stimulation of local receptors and 
eventual paralysis of nerve / muscle. 
Although organophospates differ structurally from acetyl choline they can bind to 
acetyl cholinesterase molecule at its active site and phosphorylate the serine 
moiety. When this occurs the resultant conjugate is infinitely more stable than the 
acetylcholine-acetylcholinesterase conjugate, although the endogenous hydrolysis 
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does occur. Depending upon the amount of stability and charge distribution the 
amount to hydrolysis is increased. Phosphorylated enzymes degrade very slowly 
over days to weeks making the acetyl cholinesterase essentially inactive. 
Once the acetyl cholinesterase is phosphorylated, over the next 24-48 hours an 
alkyl group is eventually lost from the conjugate, further exacerbating the 
situation. As this occurs the enzyme can no longer spontaneously hydrolyse and 
becomes permanently inactivated. 
Apart from acetyl cholinesterase, organophosphates exert powerful inhibitory 
action over other carboxylic ester hydrolases such as chymotrypsin, pseudo - 
cholinesterase, plasma and hepatic carboxyl esterases, butryl cholinesterase and 
other non-specific proteases. It has been proposed that delayed peripheral 
neuropathy caused by organophosphates is due to phosphorylation of some 
esterases other than acetyl cholinesterase such as neurotoxic esterase also known 
as neuropathy target esterase (NTE). Neuropathy caused by inhibition of NTE 
may develop 2-5 weeks after acute poisoning.   
 
Pathophyisology  
Paroxonase (PON1) is an important enzyme in the organophosphate metabolism. 
It can inactivate the organophosphate through hydrolysis. It hydrolyses the active 
metabolites of compounds and not the parent compound the presence of 
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paroxonase polymorphisms implies that to be different enzyme levels and 
efficiency of catalysis of this esterase which in turn implies that different level of 
susceptibility to the toxic effects of organophosphates.  
The level of paroxonase plasma hydrolytic activity actually provides protection 
against organophosphates. It plays as significant role in regulating the degree of 
toxicity of organophosphates depending on the type of compounds. The degree of 
protection of paroxonase depends on its catalytic efficiency. So higher its 
concentration, more will be the protection. The level of paroxonase is more in the 
adults compared to neonates. Thus the wide range in the enzyme level variability 
determines human sensitivity to organophosphates. 
 
Clinical features  
Organo phosphate compounds cause both cholinergic and nicotinic symptoms.  
1. Cholinergic excess  
a. Muscarinic effects (hollow organ parasympathetic manifestation) 
 Bronchoconstriction  
 Wheezing 
 Dyspnoea  
 Cough 
 Pulmonary oedema 
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 Vomiting  
 Diarrhoea 
 Abdominal cramps 
 Increased salivation 
 Lacrimation  
 Sweating  
 Bradycardia 
 Hypotension  
Among the above, Bradycardia and hypotension occur 
following moderate to severe poisoning.   
b. Nicotinic effects (autonomic ganglionic and somatic motor effects) 
 Fasciculation  
 Muscle Weakness  
 Hypertension 
 Tachycardia   
 Fatigability  
Hypertension can occur in up to 20 % of patients. Cardiac arrhythmias and 
conduction defects have been reported in severely poisoned patients. ECG 
abnormalities may include sinus Bradycardia / tachycardia, atrio-
ventricular conduction delay, idio-ventricular rhythm, premature 
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ventricular extra-systole, ventricular tachycardia, ventricular fibrillation, 
QT prolongation and atrial fibrillation  
 
c. CNS effects  
 Restlessness  
 Headache  
 Tremor  
 Drowsiness  
 Delirium  
 Slurred speech  
 Ataxia  
 Convulsions  
Coma is seen in later stages. Death usually results from respiratory failure 
due to weakness of respiratory muscles as well as depression of central 
respiratory drive. Non cardiogenic pulmonary oedema is a common 
manifestation of severe poisoning. Acute respiratory insufficiency is the 
main cause of death in acute OP poisoning. Metabolic acidosis has 
occurred in severe poisoning. Characteristic kerosene like odour is often 
perceptible in the patients since the solvents used in many OP insecticides 
is a derivative of petroleum. 
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Miosis as a characteristic feature may not be apparent in the initial stages. 
Blurred vision may persist for several months. 
Organophosphates rapidly produce symptoms of mucous membrane and upper 
airway irritation leading to bronchospasm following systemic absorption. Other 
cause of death in Organophosphate poisoning include hypoxia, hyperthermia, 
renal failure, hepatic failure. Patient with QT prolongation are more prone for 
respiratory failure. Aspiration of preparations leads to chemical pneumonitis. 
 
Intermediate syndrome  
It sometimes occurs 1-4 days after poisoning due the long lasting cholinesterase 
inhibition and muscle necrosis. Main feature include muscle weakness and 
paralysis characterized by motor cranial nerve palsy, weakness of neck flexors, 
proximal limb muscles and acute respiratory paresis. 
 
Paralytic signs include inability to lift the neck or sit up ophthalmoparesis, slow 
eye movements, facial weakness, difficulty in swallowing, limb weakness, 
areflexia, respiratory paralysis and death. It may be due to inadequate treatment 
of the acute episode especially involving sub therapeutic administration of 
oximes or inadequate assisted ventilation. Several investigators have proposed 
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that intermediate syndrome may develop as a result of several factors, inadequate 
oxime therapy, the dose and route of exposure, chemical structure of 
organophosphate, time taken to initiate therapy, and possibly efforts to decrease 
absorption or enhance elimination of organophosphates.  
Once it sets in the intermediate syndrome will have to be managed by supportive 
measures since it does not respond to oximes or atropines. 
 
Delayed syndrome  
It sometimes occurs 1-4 weeks after poisoning due to nerve demyelination and is 
characterized by flaccid weakness and atrophy of distal limb muscles or 
spasticity, ataxia. A missed motor sensory neuropathy usually begins in the legs 
causing burning or tingling and then weakness. This syndrome also does not 
respond to oximes or atropine. Severe cases progress to complete paralysis 
impaired respiration and death. The nerve damage of organophosphate induced 
delayed neuropathy is frequently permanent. The mechanism appears to involve 
phosphorylations of esterases in peripheral nervous tissues and results in a “dying 
back” pattern of axonal degeneration.  
Patients poisoned with highly lipid soluble organophosphates develop extra 
pyramidal effects including dystonia, resting tremor, Cog wheel rigidity, 
choreoathetosis. These effects begin 4-40 days after poisoning and spontaneously 
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resolve over 4 weeks. It is important to note that children may have different 
predominant signs of OP poisoning compared to adults, mainly CNS depression, 
stupor, flaccidity, dyspnoea and coma rather than the classical signs of OP 
poisoning. 
 
Neurotoxic effects  
Organophospates poisoning usually causes 4 neurotoxic effects in humans  
 Cholinergic syndrome  
 Intermediate syndrome  
 Organophosphate induced delayed neuropathy 
 Chronic organophosphate induced neuropsychiatric disorder. 
 
 
 
\ 
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SNAKE BITE 
Snake bites contribute to major health problems in India and continue to be a 
major medical concern. In India approximately one person is bitten by a snake 
and every two hours one case of snake bite proves fatal. Reports say that about  
10 % of deaths are of the victims who come to the hospital and about 90% die 
outside having gone for other regional remedies. 
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Epidemiology  
In India nearly four lac persons are bitten by snakes every year. Envenomation 
happens in approximately 82,000 and death occurs in 11,000 victims. Many 
deaths happen before victim reaches the hospital. Snake bite is observed all over 
the country with a rural urban ratio of 9:1 and more during monsoon and post 
monsoon season. Snake bites are often seen among agricultural workers than 
those going to the forest. Many of the susceptible populations are poor and those 
living below poverty line. They live in rural areas with less access to healthcare. 
The ratio between male to female among the victims is approximately 3:2. 
Majority are young and their age is around 25-44 years. Majority of the bites are 
noted in the extremities. The hospital stay varies from two to thirty days with 
median being four days. The in hospital mortality varies from 5-10 % and the 
causes are: 
 Acute renal failure, 
 Respiratory failure, 
 Bleeding, 
 Sepsis, 
 Multi organ failure, 
 Death. 
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Classification of snakes  
There are more than 3,000 species of snakes in the world. For the purpose of 
clinical practice, the snakes are classified into poisonous and non- poisonous 
snakes. Poisonous snakes are classified under three families and they are : 
 Cobra group (Elapidae) 
 Viper group ( Viperidae) 
 Sea snake group (Hydrophidae)  
Study of snakes of medical importance has reflected the view that four main 
species are responsible for mortality in snake bites in India. They are: 
 Indian cobra ( Naja naja) 
 Common krait (Bungarus caeruleus) 
 Russell’s viper (Daboia russelii) 
 Saw scaled viper (Echis carinatus) 
And recently Hump nosed pit viper (Hypnale hypnale) has been identified as 
being capable of causing lethal envenomation and that this problem was being 
concealed by systematic misidentification of the above four said species. 
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Statistics On Clinical Aspects Of Snake Bites And Outcomes 
Type of 
snake  
Number 
treated  
Local 
signs 
Neuro-
toxicity 
Hemo-
toxicity 
Mech. 
Vent. 
Hemo-
dialysis 
Fasci-
otomy 
No. of 
dead. 
Cobra  118 80 118 - 90 - - 2 
Krait  82 - 51 82 60 3 - 2 
Russell’s 
viper 
42 42 - 42 6 23 1 1 
Hump 
nosed 
viper 
4 4 - 4 - 4 - 1 
Saw 
scaled 
viper  
16 16 - 16 - 3 - 1 
Sea snake 3 3 - - - - - - 
Non 
poisonous 
16 6 - - - - - - 
 
Snake bite is an injury that is often a punctured wound inflicted by the fangs 
(modified teeth) of the animal sometimes leading to envenomation. 
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Most of the snake species are non-venomous which kill their prey by means of 
constriction and asphyxiation rather than envenomation. Snake bite’s outcome 
usually depends on the following factors  
 Species of the snake  
 Quantity of venom injected  
 General health condition of the person 
Bites from non-venomous snake may cause injury which is often due to the 
laceration produced by its teeth or due to subsequent infection of the bite. 
Sometimes it may even trigger an anaphylactic reaction. 
Snake venom 
Snake venom is nothing but the toxic saliva secreted by the modified parotid 
glands. It is a clear amber coloured fluid when fresh. It is the most complex of all 
poisons containing more than 20 components. The components of venom show 
diurnal and seasonal variation. Bites inflicted at night and immediately after 
hibernation are most severe. Most of the dry weight of the venom is made up of 
proteins comprising a variety of enzymes, non-enzymatic polypeptide toxins and 
non-toxic proteins. Non- protein ingredients of venom includes carbohydrates and 
metals, lipids, free amino acids, nucleotides and biogenic amines. The lethal and 
the most deleterious fractions of snake venom are certain peptides and proteins of 
relatively low molecular weight. The peptides appear to have very specific 
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receptor sites both chemically and physiologically. The role of the peptides in 
snake bites is usually overlooked by the physicians. 
The polypeptide toxins often called neurotoxins are found most abundantly in 
elapid and hydophid venoms. post synaptic alpha neurotoxins such as alpha – 
bungarotoxin and cobrotoxin contain about 60-70 amino acid residues and bind 
to acetyl choline receptors on receptor end plate. Post synaptic beta neurotoxins 
such as beta- bungarotoxin, cobrotoxin contain about 120-140 amino acid 
residues and a phospholipase A sub unit and prevent release of acetyl choline at 
the neuromuscular junction. Krait beta bungarotoxin causes an initial release of 
acetylcholine but subsequently damages the nerve terminal and prevents any 
further release. It is for this reason that krait victims often take longer time to 
recover than cobra victims.  
Enzyme function and pathological manifestations are most clearly evident in case 
of viper venom constituents. Russell’s viper venom contains 2 proteases that 
stimulate the blood clotting cascade. RVV-X, a glycoprotein activates factor X by 
a calcium dependent reaction and it also acts on factor IX and protein C. RVV-V, 
an arginine ester hydrolase activates factor V. saw scaled viper venom contains a 
Zinc metallo-protein which activates prothrombin. It is important to know that 
Russell’s viper can cause neurotoxic symptoms in addition to hemotoxic 
symptoms. 
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Hyaluronidase may serve to promote the spread of venom through tissue. 
Proteolytic enzymes may be responsible for local changes in vascular 
permeability leading to oedema, blistering and bruising and finally necrosis. 
Biological amines such as histamine and 5 hydroxy tryptamine may contribute to 
local pain and permeability changes at the site of snake bite. Since snake venom 
is mostly comprised of protein, it is not surprizing that anaphylactic shock can be 
induced if a person is bitten by the same species of snake the second time after a 
variable interval following the first bite.  
The variation of venom composition from species to species explains the clinical 
diversity of snake bites. There is also considerable variation in the concentration 
of different venom constituents within the same species in different geographical 
locations and seasons. Sea snake venom contains  
 Hylauronidase  
 Acetyl cholinesterase 
 Leucine amino-peptidase 
 Phospholipase 
 Phospho-monoesterase. 
 Phospho-diesterase 
 5’ nucleotidase 
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SYMPTOMATOLOGY OF ELAPID BITE 
 
 
Local effects  
Mild pain and swelling with blistering and tenderness, sometimes causing 
early onset of gangrene. Contact of the venom with the eye results in 
venom ophthalmia characterized by intense irritation, conjunctivitis, 
corneal erosion, anterior uveitis and secondary infection 
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Systemic effects  
 Neurotoxicity is the dominant clinical feature of elapid bites. It consists of 
mainly two stages  
a. Pre- Paralytic stage  
 Vomiting 
 Ptosis  
 Blurred vision  
 External ophthalmoplegia 
 Paraesthesia around the mouth 
 Hyperacusis  
 Headache  
 Myalgia 
 Vertigo  
 Hyper-salivation  
b. Paralytic stage  
Facial muscles, muscle of articulation and deglutition all become 
progressively flaccidly paralysed. Respiratory arrest may occur due 
to obstruction of paralysed tongue or due to paralysis of intercostal 
muscles and diaphragm. Loss of consciousness and convulsions are 
terminal phenomena resulting from hypoxemia. 
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Neurotoxicity, if it develops, generally begins 1-5 hours after envenomation but 
may be delayed as long as 19 hours. Cranial nerve palsy is found in some 
patients.  
 
General features of envenomation of viperidae   
 Swelling and local pain 
 Enlargement of regional nodes 
 Bleeding from gingiva and epistaxis 
 Abdominal tenderness due to gastrointestinal bleeding 
 Petechiae, purpura, ecchymosis 
 Low back pain- indicator of early renal failure  
 Hemoglobinuria  
 Lateralizing neurological signs indicative of intracranial bleeding 
 External ophthalmoplegia, ptosis, dysphagia 
 Deep vein thrombosis and compartment syndrome 
The actual strength of the snake venom differs considerably between different 
family and species and its strength is measured as Median Lethal Dose (LD50) in 
mice.  Amount of venom produced also greatly differs between the snake species 
and families. Earlier particular snake venom was considered either neurotoxic or 
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hemotoxic but the updated literature clearly explains the complex nature and 
composition of snake venom. 
Feature  Cobra  Krait  Russell’s viper  Saw scaled 
viper  
Hump nosed 
viper 
Local pain / 
tissue damage  
Yes  No  Yes  Yes  Yes  
 Ptosis / 
neurological 
signs  
Yes  Yes Yes  No  No  
Hemostatic 
abnormalities  
No  No  Yes  Yes  Yes  
Renal 
complications  
No  No  Yes  No  Yes  
Response to 
neostigmine  
Yes  No  No  No No  
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MATERIALS AND METHODS 
Study place   
Rajiv Gandhi Govt. General Hospital, 
Chennai  - 600 003. 
 
Collaborating department  
Upgraded Institute of Otorhinolaryngology, 
Department of audiology 
Institute of internal medicine  
Study design  
Retrospective study  
Study period  
July 2013 to October 2014. 
  
Inclusion criteria  
1. Age of the individual – 20-35 years  
2. No previous history of  
i. Ear discharge 
ii. Hard of hearing  
iii. Tinnitus  
iv. Vertigo 
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v. Noise exposure  
vi. Intake of ototoxic drugs  
3. Normal and intact tympanic membrane on otoscopic examination  
4. Pure tone audiometric thresholds within normal limits. 
 
Exclusion Criteria  
1. Age less than 15 years  
2. Age above 35 years 
3. Previous history of  
i. Ear discharge 
ii. Hard of hearing  
iii. Tinnitus  
iv. Vertigo 
v. Noise exposure  
vi. Intake of ototoxic drugs  
4. Abnormal tympanic membrane findings  
i. Perforation  
ii. Retraction  
iii. Cholesteatoma 
iv. Atlectatic tympanic membrane  
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Pre-workup procedure 
Detailed history of the condition of the patient prior to admission in the hospital 
for treatment of organophosphate poisoning /  neurotoxic snake bite.  
 
Detailed Initial Assessment Of The Patient.  
Proforma  
1. Name : 
2. Age :  
3. Sex  : 
4. Cause of admission :  OP poisoning / neurotoxic snake bite 
5. Hospital No.: 
6. Occupation : 
7. Address : 
8. Contact No.: 
9. Date of admission : 
10. Questionnaire  
Previous history of.. Yes No 
Ear discharge    
Hard of hearing    
Tinnitus    
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Vertigo    
Exposure to noise    
Intake of ototoxic drugs   
Trauma    
 
11. Examination  
a. General examination  
i. Level of consciousness  
ii. Ventilator support – present / absent  
iii. Vital signs  
1. Pulse  
2. Blood pressure  
3. Respiratory rate 
4. Temperature  
b. Systemic examination  
i. Respiratory system  
ii. cardiovascular system 
iii. central nervous system 
iv. per abdomen  
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c. ENT examination  
i. EAR 
Part  Right  Left  
Pinna    
Pre-auricular region    
Post auricular region    
External auditory canal    
Tympanic membrane  
 Perforation 
 Retraction  
 Cholesteatoma 
 Atelectasis 
    Yes / no      Yes / no  
 
DPOAE 
 Right ear  Left ear  
Present    
Absent    
 
Pure tone audiometry  
Special audiological tests  
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AUDX pro measurement system  
“It uses both hardware and software to carry out the testing.  AUDX pro usually 
produces some controlled type of acoustic signal in external auditory canal and 
helps to measure the evoked emission that are usually generated in cochlear outer 
hair cells. This system usually averages the collected data samples until 
measurement parameters are achieved in a specified one. 
For DPOAEs, noise of the floor is usually seen on the LCD screen. A “PASS” or 
“REFER” criterion is usually assigned mainly based on comparison of 
Otoacoustic emissions of patients at the end of the test in response to a data that 
has been normalized. Clinician needs to see and interpret the results. 
The AUDXpro contains a large colour display that supports graphical icons and 
means to facilitate programme operation and can display test data graphically. It 
comprises of a total of seven membranes which switch to manoeuvre through the 
program menu and operations”.  
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AUDXpro is a medical device that produces information about the auditory 
system of the patient. This information is then available for medical diagnosis or 
screening.  
 
Ear probe instructions  
Removal and cleaning of probe nozzle 
“The ear piece is usually a easily disposable one. If nozzle probe is found 
to contain any debris or dirt, we need to clean it carefully with tissue paper 
or cotton pads mainly along the grooves. We need to ensure that we clean 
from the base to apex. This will help in preventing the debris to go back to 
the groove space mainly through the channels. the nozzle is cleaned with 
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spirit. There should be no over-usage of spirit. There are usually clips 
which are found in the nozzle to attach it securely to the body of the probe. 
The clip at the base is very smooth to touch. The apex of the clip has one 
more plastic ridge found on its surface”. 
 
Installation of Replacement probe nozzle 
To install a nozzle on to the probe body, align the clips in the probe nozzle 
with the corresponding slots on the probe body. Be sure that the probe 
nozzle component is oriented in such a way that the shape of the cavity 
matches the shape of the probe body, once the two pieces are aligned to 
match, slide the nozzle clips and fix until they lock with each other well. 
Make sure that the nozzle component is securely attached to the probe 
body. 
 
 Foam ear tips  
 The tube is properly inserted into the nozzle of the probe. 
 Make sure that the tube fully covers the nozzle. 
 There should be no gap found at the bottom between the nozzle 
and the tip 
 Handle with care while removing the foam from the tube. 
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Indications for use  
“The AUDXpro Otoacoustic emission measurement system when 
placed in the external ear canal usually produces an acoustic signal and 
the Otoacoustic emission evoked in response to the signal which are 
produced from the cochlear outer hair cells are measured. It performs 
measurements of both TOAES and DPOAEs which can be used for 
screening and diagnostic purposes. 
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Environment and patient preparation 
“There is not much need for specific preparation for OAE testing. Since the 
test usually records a normal physiological occurrence, there is not much  
response needed from the subject. Hence these emission testing can be done in 
patients who are unconsciousness and who are in a stage of coma. 
The only thing needed is the cooperation of the person to not remove the 
ear probes from his / her ear canal till the testing is finished. Duration of the test 
depends on the subject’s emission, noise from the background, and the 
parameters of the test.  
Since in this test, the probe in the outer ear usually measures soft sounds, 
the back ground noise should be kept in control and the test will be relatively 
quicker if we proceed according to this, keeping the background noises are very 
low. If possible, perform testing in a quiet environment”. 
 
Patient preparation  
 “The otoscopic examination of the external ear is mandatory before 
placing the probe in the ear. Make sure the outer ear is free from 
wax since it can interfere with testing of the person. The testing is 
usually not advised for persons with active ear discharge. 
. 
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 Since there are variety of probes depending on the size, we need to 
use correct size of the probe depending on the size of ear canal, 
preferably use a larger ear tip since smaller ones may lead to 
improper results.  
 After insertion of the tip in the patient’s outer ear give few seconds 
for its expansion inside the ear canal.  
 For uncooperative children clipping of the probe to the shirt may be 
done.  
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Patient instructions   
For well cooperative and oriented persons, the information need to be conveyed 
are  
 the ear tip need to be inserted in the outer ear 
 a series of sounds of short span  will be heard by him / her. 
 The testing will be more precise and quick if he remains silent 
throughout the testing. 
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T-TEST 
 
The mean age of subjects in “Cases” (organophosphate ingested and neurotoxic 
snake bites victims)  group was 28.36 years and the mean age of persons in 
control group was 25.74 years. 
 
 
 
The independent samples and their variances using Levine’s test have been 
computed and the t test for equality of means has been arrived along with the 
confidence interval of the difference. 
 
 
 
Group Statistics
50 28.36 8.727 1.234
50 25.74 2.431 .344
Group
Case
Control
Age
N Mean Std.  Dev iation
Std.  Error
Mean
Independent Samples Test
30.861 .000 2.045 98 .044 2.620 1.281 .078 5.162
2.045 56.561 .046 2.620 1.281 .054 5.186
Equal variances
assumed
Equal variances
not assumed
Age
F Sig.
Levene's Test f or
Equality  of  Variances
t df Sig. (2-tailed)
Mean
Dif f erence
Std.  Error
Dif f erence Lower Upper
95% Conf idence
Interv al of  the
Dif f erence
t-test  for Equality  of  Means
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Crosstabs 
Sex Group 
Among 50 cases and 50 controls, there were 62 % males and 38 % females. 
 
 
 
 
 
    
Crosstab
37 25 62
74.0% 50.0% 62.0%
13 25 38
26.0% 50.0% 38.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Male
Female
Sex
Total
Case Control
Group
Total
Chi-Square Tests
6.112b 1 .013
5.136 1 .023
6.192 1 .013
.023 .011
6.051 1 .014
100
Pearson Chi-Square
Continuity  Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of  Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only  f or a 2x2 tablea. 
0 cells (.0%) hav e expected count less than 5. The minimum expected count is 19.
00.
b. 
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Organophosphates  poisoning / neurotoxic Snakebite * Group 
Among the cases, 50 % were Organophosphate poisoned and other 50% were 
neurotoxic snake bite victims. 
 
 
 
 
 
 
 
Crosstab
25 25
50.0% 50.0%
25 25
50.0% 50.0%
50 50
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
OP. Poisoning
Snake Bite
organophos-phorous 
poisoning /  Snakebite
Total
Case
Group
Total
Chi-Square Tests
.a
50
Pearson Chi-Square
N of  Valid Cases
Value
No statistics are computed
because Group is a constant.
a. 
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Previous H/O HOH,  Ear discharge  Tinnitus, Vertigo * Group 
All cases and controls did not have previous history of hard of hearing, tinnitus, 
ear discharge, vertigo. 
 
 
 
 
 
 
 
Crosstab
50 50 100
100.0% 100.0% 100.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
NoPrev ious 
H/O HOH,
Ear discharge 
Tinnitus, Vert igo
Total
Case Control
Group
Total
Chi-Square Tests
.a
100
Pearson Chi-Square
N of  Valid Cases
Value
No statistics are computed because
Prev ious 
H/O HOH,
Ear discharge 
Tinnitus,  Vertigo is a constant.
a. 
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Tympanic Membrane Group 
The tympanic membrane was found to be intact in all cases and controls. 
 
 
 
  
 
 
 
 
 
Crosstab 
50 50 100 
100.0% 100.0% 100.0% 
50 50 100 
100.0% 100.0% 100.0% 
Count 
% within Group 
Count 
% within Group 
BETM intact Tympanic  
Membrane 
Total 
Case Control 
Group 
Total 
Chi-Square Tests 
. a 
100 
Pearson Chi-Square 
N of Valid Cases 
Value 
No statistics are computed because 
Tympanic  
Membrane is a constant. 
a.  
83 
 
Pure Tone Audiometry group 
The pure tone audiometry was found to be normal in both cases and controls. 
 
 
 
 
 
 
 
 
 
 
Crosstab
50 50 100
100.0% 100.0% 100.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
NoPTA
Total
Case Control
Group
Total
Chi-Square Tests
.a
100
Pearson Chi-Square
N of  Valid Cases
Value
No statistics are computed because PTA is a constant.a. 
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Crosstabs 
DPOAE - Right Group 
Among the 50 cases DPOAE was present in 10% and absent in 90% whereas in 
controls DPOAE was found to be present in 86% and absent in 14% on the right 
side. 
 
 
Crosstab
5 43 48
10.0% 86.0% 48.0%
45 7 52
90.0% 14.0% 52.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Present
Absent
DPOAE
- RT
Total
Case Control
Group
Total
Chi-Square Tests
57.853b 1 .000
54.848 1 .000
65.465 1 .000
.000 .000
57.274 1 .000
100
Pearson Chi-Square
Continuity  Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of  Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only  f or a 2x2 tablea. 
0 cells (.0%) hav e expected count less than 5. The minimum expected count is 24.
00.
b. 
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DPOAE - LT * Group 
Among the 50 cases DPOAE was present in 10% and absent in 90% whereas in 
controls DPOAE was found to be present in 86% and absent in 14% on the left 
side. 
 
 
Risk Estimate
.018 .005 .061
.120 .052 .278
6.655 3.318 13.346
100
Odds Ratio f or DPOAE -
RT (Present / Absent)
For cohort  Group = Case
For cohort  Group =
Control
N of  Valid Cases
Value Lower Upper
95% Conf idence
Interv al
Crosstab
5 43 48
10.0% 86.0% 48.0%
45 7 52
90.0% 14.0% 52.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Present
Absent
DPOAE
- LT
Total
Case Control
Group
Total
86 
 
 
 
 
Chi-Square Tests
57.853b 1 .000
54.848 1 .000
65.465 1 .000
.000 .000
57.274 1 .000
100
Pearson Chi-Square
Continuity  Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of  Valid Cases
Value df
Asy mp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only  f or a 2x2 tablea. 
0 cells (.0%) hav e expected count less than 5. The minimum expected count is 24.
00.
b. 
Risk Estimate
.018 .005 .061
.120 .052 .278
6.655 3.318 13.346
100
Odds Ratio f or DPOAE -
LT (Present / Absent)
For cohort  Group = Case
For cohort  Group =
Control
N of  Valid Cases
Value Lower Upper
95% Conf idence
Interv al
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Comparison between cases and control in age  
 Age in years  
Cases  28.36  
Control  25.74 
 
 
 
 
 
Among the cases (neurotoxic snake bite victims and organophosphate poison 
ingested persons), mean age was found to be 28.36 and among the controls  
(normal population) mean age was 25.74 years 
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Comparison between cases and control in sex 
 Cases  Controls 
Males  74 50 
Females  26 50 
 
 
 
 
Among the cases (neurotoxic snake bite victims and organophosphate poison 
ingested persons), 74 % were males and 26 % were females. Among the controls 
the males and females were in equal proportion. 
89 
 
Comparison between cases and control in DPOAE right  
 Cases  Control  
Present  10 86 
Absent  90 14 
 
 
 
Among the 50 cases DPOAE was present in 10% and absent in 90% whereas in 
controls DPOAE was found to be present in 86% and absent in 14% on the right 
side. 
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Comparison between cases and control in DPOAE left   
 Cases  Control  
Present  10 86 
Absent  90 14 
 
 
 
Among the 50 cases DPOAE was present in 10% and absent in 90% whereas in 
controls DPOAE was found to be present in 86% and absent in 14% on the left 
side. 
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Comparison between OPC and snake bite  
Organophospates  50 
Snake bite  50 
 
 
 
Among the cases 50% were those persons who had deliberately 
ingested organophosphate poison and the remaining 50 % were victims 
of neurotoxic snake bites. 
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DISCUSSION 
Otoacoustic emissions are produced by the cochlea. These are low intensity 
sounds produced in response to acoustic stimulus. Deliberate self -poisoning by 
organophosphates has become an increasingly common response to emotional 
stress and depression in the young adult population of India. They comprise about 
seventy six per cent of pesticide poisoning in total. Several organophosphate 
pesticides have neurotoxins which have a great potential to affect hearing and 
animal studies show change in the threshold of hearing and outer and inner hair 
cell damage following organophosphate ingestion. But such studies in humans 
are very few.  
Another major cause of poisoning apart from organophosphates are accidental 
snake bites many of which are neurotoxic. Neurotoxic snakes have a great 
potential to cause functional alterations of hair cells and hearing by the effects of 
their neurotoxins. Snake bite is an injury caused by bite from a snake, often 
resulting in puncture or wounds inflicted by the animal’s fangs and sometimes 
resulting in envenomation. Usually snake bite presents with symptoms of 
drowsiness, abdominal pain, neurologic or neuromuscular manifestations such as 
ptosis, dysphagia, blurring of vision, ataxia, and headache. Hearing loss is a rare 
symptom followed by snake bite. Only few case studies on hearing loss following 
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snake bite are reported in the literature [5]. The venom of Bungarus caeruleus 
(krait) contains a mixture of alpha,beta-bungarotoxin and caerulotoxin [2].  
Alpha-bungarotoxins cause failure of neuromuscular transmission by binding to 
post synaptic AchR at neuromuscular junction, Beta-bungarotoxins contains 20% 
protein content of the venom and are most toxic components of the venom. They 
are pre-synaptically active neurotoxic phospholipases [2].Exposure to these 
toxins in vivo and in vitro causes the failure of neuromuscular transmission for 
two to three hours and depletion of synaptic vesicles from the nerve terminal 
endings. Caerulotoxin.  a minor component of the venom , found exclusively in 
kraits and are structurally similar to alpha-bungarutoxins. Alpha bungarutoxin 
and caerulotoxin act on post synaptic membrane. 
Need of the study  
The advantages of the Otoacoustic Emission testing include 
 Non-invasive nature   
 Objectivity,  
 Sensitivity,  
 Specificity,  
 Accuracy and  
 Reliability  
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These advantages help in easily assessing the minor / sub clinical changes in the 
outer hair function even before they are clinically apparent. 
Literature suggests damage to the auditory system due to the solvent exposure of 
organophosphates in occupational settings. So it is clearly inferred that damage to 
auditory system will be more serious due to direct ingestion of organophosphates 
orally. Hence the purpose of the present study is to ascertain the functional 
alterations in cochlear outer hair cells in the persons who deliberately ingested the 
organophosphate compounds and the victims of neurotoxic snake bites.  
As it has been clearly explained previously, the mechanism of action of 
neurotoxic snake venom is very much similar to that of organophosphates. Hence 
it is very much possible that the neurotoxic snake venom could also possible 
result in functional alterations in the cochlea and in outer hair cells like the 
organophosphate compounds.  
In numerous literatures researchers have concluded changes in Otoacoustic 
emissions precedes the changes in the hearing in those patients receiving drugs 
having ototoxic potential wherein the pure tone audiometric thresholds were 
found to be normal within the conventional frequency range.  
The above said great range of susceptibility of Otoacoustic emission to the 
ototoxic damage has been compared to behavioural testing reflect distortion 
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product Otoacoustic emissions’ sensitivity to the sub clinical changes in the 
cochlear outer hair cell function.  
The above mentioned evidence supports the potential use of Otoacoustic emission 
testing clinically for very early detection of organophosphate solvent induced 
functional alterations in outer hair cells of cochlea and hearing loss. It implies 
decrease in the distortion product Otoacoustic emission is found to occur very 
early, even before the onset of changes in the hearing threshold becomes 
clinically apparent. So it is possible for us to predict the further changes in the 
hair cells and also to predict future hearing loss. 
Hence there is a need for identification of the changes occurring in the distortion 
product Otoacoustic emission following deliberate ingestion of organophosphate 
poisoning and in snake bites and helps us to explore the cochlear changes among 
the individuals in whom the audiometric thresholds are found to be within the 
normal limits.  
Procedure  
The subjects who underwent the study have been divided into two groups.  
 Group 1  
 Group 2 
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Group 1 included those persons who had deliberately ingested organophosphate 
compounds orally and those persons who had been victims of neurotoxic snake 
bites. 
Group 2 included normal persons. 
Both Group 1 & Group 2 were matched for the following criteria 
Inclusion criteria 
1. Age of the individual – 20-35 years  
2. No previous history of  
i. Ear discharge 
ii. Hard of hearing  
iii. Tinnitus  
iv. Vertigo 
v. Noise exposure  
vi. Intake of ototoxic drugs  
3. Normal and intact tympanic membrane on otoscopic examination  
4. Pure tone audiometric thresholds within normal limits. 
 
Exclusion Criteria  
1. Age less than 15 years  
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2. Age above 35 years 
3. Previous history of  
i. Ear discharge 
ii. Hard of hearing  
iii. Tinnitus  
iv. Vertigo 
v. Noise exposure  
vi. Intake of ototoxic drugs  
4. Abnormal tympanic membrane findings  
i. Perforation  
ii. Retraction  
iii. Cholesteatoma 
iv. Atlectatic tympanic membrane  
 Once the appropriate patients were selected according to the above criteria, they 
were evaluated by testing of Distortion product Otoacoustic Emission testing. 
The results were mainly grouped under two categories, “pass” or “fail” criteria.  
The responses were considered as “pass” only if seven out of nine frequencies 
were found to be above six decibel noise level.  The responses were considered 
“fail” if less than seven frequencies were above the six dB noise level. 
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Results  
Distortion product Otoacoustic emissions findings of the above said two groups 
revealed the “pass” or “fail” criteria. 
 
In Group 1, i.e., who had the deliberate ingestion of Organophosphate poison 
and victims of neurotoxic snake bites, were found to have  
 “Passed” criteria  - 10 % 
 “Failed” criteria  - 90 % 
In Group 2, i.e., healthy subjects  
 “Passed” criteria  -86 % 
 “Failed” criteria – 14 % 
The “failed” criteria result of distortion product Otoacoustic emission in     
Group 1,  were found to be noticed bilaterally, which clearly infers the absence 
of DPOAEs in both the ears. 
The “failed” criteria results of DPOAEs of both the groups were compared and 
Chi square analysis has been done and it has been found to be statistically 
significant one. 
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The current study shows significant failure statistically while measuring DPOAEs 
in Group 1 subjects, clearly explains the changes in the cochlea following 
Organophosphate poisoning and neurotoxic snake bite. 
The important underlying pathology in organophosphate poisoning and in 
neurotoxic snake bite is  
 Generation of reactive oxygen species 
 Depletion of NADPH, which is essential for the normal functioning of 
the cell  
Studies and literature suggest that the root of intoxication of these neurotoxic 
compounds to the inner ear need to be blood borne from the stria vascularis. Also 
these compounds readily diffuse through the lipid rich contents of the membranes 
and through the cells of Hensen which are in close relation to the Deiter cells and 
they are found to be located under the outer hair cells and thus the target site has 
been reached. Hence the current study explains the functional alterations in the 
cochlea which has been represented by the significant absence of Distortion 
product Otoacoustic Emission in the study group. And this study infers that 
exposure to organophosphates and neurotoxic snake venom may contribute to 
hearing loss. The future research should be focussed on determining the 
frequency specific responses of the distortion product Otoacoustic emissions 
which will be of great use. 
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Conclusion 
Our current study clearly concludes the significant functional changes in the outer 
hair cells of the cochlea following deliberate ingestion of organophosphate 
compounds and neurotoxic snake bite which has been clearly reflected by the 
presence of “Failed” criteria found in the distortion product Otoacoustic 
emissions of the above said groups. So these agents may induce auditory damage 
not only in the animals (which has been clearly proved in the literature and 
animal studies) but also in humans. The clinician should be alert to the ototoxic 
potentials of organophosphate compounds and neurotoxic snake bites and needs 
to conduct a comprehensive assessment of the auditory system periodically on 
these patients in order to predict the hearing loss in future and institute early and 
appropriate rehabilitative measures. 
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MASTER CHART (CASES) 
S. No. Name Age Sex IP No. 
organopho
sphate 
poisoning / 
Snakebite 
Previous  
H/O HOH, 
 Ear discharge  
Tinnitus, Vertigo 
Tympanic  
Membrane 
PTA 
DPOAE 
RT LT 
1 Shankar 25 M 77327 
OP. 
Poisoning No BETM intact N Absent Absent 
2 Karthikeyan 35 M 79086 
OP. 
Poisoning No BETM intact N Absent Absent 
3 Govindraj 24 M 81427 
OP. 
Poisoning No BETM intact N Absent Absent 
4 
 
 
Vignesh 21 M 84331 
OP. 
Poisoning No BETM intact N Absent Absent 
5 Iyyapan 24 M 85363 
OP. 
Poisoning No BETM intact N Absent Absent 
  
 
 
6 Boopathy 20 M 86175 
OP. 
Poisoning No BETM intact N Absent Absent 
7 Kabilan 29 M 88421 
OP. 
Poisoning No BETM intact N Absent Absent 
8 chella Durai 32 M 88422 
OP. 
Poisoning No BETM intact N Absent Absent 
9 Ramadurai 21 M 88454 
OP. 
Poisoning No BETM intact N Absent Absent 
10 Santhosh 29 M 88418 
OP. 
Poisoning No BETM intact N present present 
11 Karthick 29 M 88423 
OP. 
Poisoning No BETM intact N Absent Absent 
12 
 
 
Kullammal 30 F 20267 
OP. 
Poisoning No BETM intact N Absent Absent 
13 Ilayaraja 35 M 20188 
OP. 
Poisoning No BETM intact N Absent Absent 
 
 
14 Vijay Kumar 25 M 18913 
OP. 
Poisoning No BETM intact N Absent Absent 
15 Parthiban 27 M 17358 
OP. 
Poisoning No BETM intact N Absent Absent 
16 Edwin 34 M 16953 
OP. 
Poisoning No BETM intact N Absent Absent 
17 Muthu 28 M 12540 
OP. 
Poisoning No BETM intact N Absent Absent 
18 Aruna 18 F 12343 
OP. 
Poisoning No BETM intact N Absent Absent 
19 Usha 23 F 11331 
OP. 
Poisoning No BETM intact N Absent Absent 
20 Gomathy 18 F 11315 
OP. 
Poisoning No BETM intact N present present 
21 
 
Narayana 
Moorthy 23 M 10900 
OP. 
Poisoning No BETM intact N Absent Absent 
 
 
22 Gopinath 34 M 8376 
OP. 
Poisoning No BETM intact N Absent Absent 
23 Selva Kumar 21 M 122905 
OP. 
Poisoning No BETM intact N Absent Absent 
24 Ramakrishnan 24 M 5970 
OP. 
Poisoning No BETM intact N Absent Absent 
25 Sabarirajan 21 M 15694 
OP. 
Poisoning No BETM intact N Absent Absent 
26 Sundari 30 F 45214 Snake Bite No BETM intact N Absent Absent 
27 murugan 18 M 77696 Snake Bite No BETM intact N Absent Absent 
28 Sowmya 13 F 79273 Snake Bite No BETM intact N Absent Absent 
29 Mani 35 F 81031 Snake Bite No BETM intact N Absent Absent 
30 Easwaran 37 M 81470 Snake Bite No BETM intact N present present 
31 Haridoss 34 M 81110 Snake Bite No BETM intact N Absent Absent 
32 Chinna Ponnu 46 F 81778 Snake Bite No BETM intact N Absent Absent 
33 Venkatachalam 45 M 82725 Snake Bite No BETM intact N Absent Absent 
34 Athimohan 36 M 84679 Snake Bite No BETM intact N Absent Absent 
 
 
35 Lakshmi 21 F 84478 Snake Bite No BETM intact N Absent Absent 
36 Sakunthala 28 F 85305 Snake Bite No BETM intact N Absent Absent 
37 Mani 36 M 85717 Snake Bite No BETM intact N Absent Absent 
38 N agaraj 28 M 78184 Snake Bite No BETM intact N Absent Absent 
39 Ammainathan 35 M 87227 Snake Bite No BETM intact N Absent Absent 
40 Selvam 60 M 72117 Snake Bite No BETM intact N present present 
41 Prakash 25 M 77153 Snake Bite No BETM intact N Absent Absent 
42 Srinivasan 36 M 68419 Snake Bite No BETM intact N Absent Absent 
43 Thiru 32 M 132413 Snake Bite No BETM intact N Absent Absent 
44 Kuppu 30 F 95038 Snake Bite No BETM intact N Absent Absent 
45 Menaka 29 F 98734 Snake Bite No BETM intact N Absent Absent 
46 Sneha 12 F 68417 Snake Bite No BETM intact N Absent Absent 
47 Ajith Kumar 16 M 72417 Snake Bite No BETM intact N present present 
48 Gokul 20 M 84329 Snake Bite No BETM intact N Absent Absent 
49 Saravanan 32 M 68457 Snake Bite No BETM intact N Absent Absent 
50 Nagaraj 34 M 89117 Snake Bite No BETM intact N Absent Absent 
 


ÑV Jl×Rp T¥Ym 
BnÜ ùNnVlTÓm RûXl× 
 
 L¦U TôvTWv éf£dùLôp- UÚkÕ EhùLôiP Utßm SfÑ Tôm× L¥Vôp 
Tô§dLlThP úSôVô°LÞdÏ EsLô§p (SjûR GÛm×) HtTÓm Tô§l×Ls (ÖiùQô- 
AûXÅfÑ UôßTôÓLs  OAE)” Tt±V BnÜ. 
 
BWônf£ ¨ûXVm     : WôËq Lôk§  
AWÑ ùTôÕ UÚjÕYUû] 
       ùNuû] UÚjÕYd Lpí¬, 
       ùNuû] – 600 003. 
TeÏ ùTßTY¬u ùTVo   : 
TeÏ ùTßTY¬u Gi   : 
TeÏ ùTßTYo CRû] (  ) Ï±dLÜm : 
 
 úUúX Ï±l©hÓs[ UÚjÕY Bn®u ®YWeLs G]dÏ ®[dLlThPÕ. 
GuàûPV NkúRLeLû[ úLhLÜm, ARtLô] RÏkR ®[dLeLû[ ùT\Üm 
YônlT°dLlThPÕ. 
 Sôu CqYôn®p Ru²fûNVôLRôu TeúLt¡ú\u. GkR 
LôWQj§]ôúXô GkR LhPj§Ûm GkR LhP £dLÛdÏm EhTPôUp Sôu 
CqYôn®p CÚkÕ ®X¡ ùLôs[Xôm Gußm A±kÕ ùLôiúPu. 
 CkR BnÜ NmUkRUôLúYô, CûR NôokR úUÛm BnÜ úUtùLôÞm úTôÕ 
CkR Bn®p TeÏùTßm UÚjÕYo GuàûPV UÚjÕY A±dûLLû[ 
TôoTRtÏ Gu AàU§ úRûY«pûX G] A±kÕ ùLôs¡ú\u. Sôu Bn®p 
CÚkÕ ®X¡d ùLôiPôÛm CÕ ùTôÚkÕm G] A±¡ú\u. 
 CkR Bn®u êXm ¡ûPdÏm RLYpLû[Ùm, T¬úNôRû] 
Ø¥ÜLû[Ùm Utßm £¡fûN ùRôPoTô] RLYpLû[Ùm UÚjÕYo 
úUtùLôsÞm Bn®p TVuTÓj§d ùLôs[Üm AûR ©WÑ¬dLÜm Gu ØÝ 
U]ÕPu NmU§d¡ú\u. 
 CkR Bn®p TeÏ ùLôs[ Jl×dùLôs¡ú\u. G]dÏ ùLôÓdLlThP 
A±ÜûWL°uT¥ SPkÕ ùLôsYÕPu CkR BnûY úUtùLôsÞm UÚjÕY 
A¦dÏ EiûUÙPu CÚlúTu Gußm Eß§V°d¡ú\u. G] EPp SXm 
Tô§dLlTPThPôúXô ApXÕ G§oTôWôR YZdLj§tÏ Uô\ô] úSônÏ± 
ùRuThPôúXô EPú] AûR UÚjÕY A¦«Pm ùR¬®lúTu G] Eß§ 
A°d¡ú\u. 
 CkR Bn®p G]dÏ CWjRm, £ß¿o, GdvúW, vúLu T¬úNôRû] ùNnÕ 
ùLôs[ Sôu ØÝ U]ÕPu NmU§d¡ú\u. 
 TeúLtTY¬u ûLùVôlTm ……………………CPm ……………úR§ 
 LhûP®Wp úWûL 
 TeúLtTY¬u ùTVo Utßm ®XôNm………………………………………… 
 BnYô[¬u ûLùVôTTm …………………….CPm ………………úR§ 
 BnYô[¬u ùTVo…………………………………………………………….. 
  
 
 
BnÜ RLYp Rôs 
 
BWônf£ RûXl×  :  L¦U TôvTWv éf£dùLôs° UÚkÕ 
EhùLôiP Utßm SfÑ Tôm× L¥Vôp 
Tô§dLlThP úSôVô°LÞdÏ EsLô§p (SjûR 
GÛm×) HtTÓm Tô§l×Ls ÖiùQô- 
AûXÅfÑ UôßTôÓLs (OAE) 
 
BWônfNô[o ùTVo : UÚjÕYo Bo.®.Gv úYXYu  
  (LôÕ êdÏ ùRôiûP ØÕ ¨ûX UÚjÕY 
UôQYo) 
 
TeúLtTô[o ùTVo  : 
 
 ùNuû] WôËqLôk§ AWÑ UÚjÕYUû]dÏ YÚm L¦U TôvTWv 
éf£dùLôs° UÚkÕ EhùLôiP Utßm SfÑ Tôm× L¥Vôp Tô§dLlThP 
úSôVô°LÞdÏ (SjûR GÝm×) HtTÓm Tô§l×Ls (ÖiùQô- AûXÅfÑ UôßTôÓLs 
(OAE) Tt±V BWônf£VôÏm. 
 NlR Nd§«u çiÓRXôp SjûR GÛm× (EsùN®) ÖiùQô- AûXÅf£û] 
(OAE) ùY°lTÓjÕ¡\Õ. CkR ÖiùQô- AûXÅfÑ UôßTôÓLû[ A[ÅÓ 
ùNnYRu êXm SjûR GÛm× GkR A[Ü Tô§dLlThÓ úLhÏm §\u Ïû\¡\Õ 
GuTûR Õp-VUôL A±V Ø¥Ùm. 
 úUtLiP úSôVô°L°u SjûR (GÛm×) (Es LôÕ) Tô§l× Ut\m úLhÏm 
§\²p HtTÓm Ïû\TôûP ÖmùQô- AûXÅfÑ UôßTôÓLû[ (OAE)  A[ÅÓ 
ùNnYRu êXm A±V Ø¥Ùm. 
 ¿eLs CkR BWônf£«p TeúLtL SôeLs ®Úm×¡ú\ôm. 
 CkR BWônf£«u Ø¥ÜLû[ ApXÕ LÚjÕLû[ ùY°«ÓmúTôúRô ApXÕ 
BWônf£«uúTôRô ReL[Õ ùTVûWúVô ApXÕ AûPVô[eLû[úVô ùY°«P 
UôhúPôm GuTûRÙm ùR¬®jÕd ùLôs¡ú\ôm. 
 CkR BWônf£«p TeúLtTÕ ReLÞûPV ®ÚlTj§u úT¬pRôu CÚd¡\Õ. 
úUÛm ¿eLs GkúSWØm CkR BWônf£«-ÚkÕ ©uYôeLXôm GuTûRÙm ùR¬®jÕd 
ùLôs¡ú\ôm. 
 CkR BWônf£«u Ø¥ÜLû[ BWônf£«uúTôÕ ApXÕ BWônf£«u 
Ø¥®uúTôÕ ReLÞdÏ A±®dLlTÓm GuTûRÙm ùR¬®jÕd ùLôs¡ú\ôm. 
 
BWônf£Vô[o ûLùVôlTm       TeúLtTô[o ûLùVôlTm 
 
úR§ : 
Certi
 
Submit: Single File Upload 
Congratulations - your submission is complete! This is your digital receipt. 
You can print a copy of this receipt from within the Document Viewer. 
Author: 
221214004.ms Ent VELAVAN R V S 
Assignment title: 
TNMGRMU EXAMINATIONS 
Submission title: 
EFFECT OF DELIBERATE INGESTION OF ORGANOPHOSPHATE PESTICIDES AND 
SNAKE BITES ON DISTORTION PRODUCT OTOACOUSTIC EMISSION (DPOAE)” 
File name: 
dissertation for plagiarism.docx 
File size: 
9.61M 
Page count: 
105 
Word count: 
10791 
Character count: 
62564 
Submission date: 
20-Sep-2014 15:07 IST 
Submission ID: 
454423574 
«  Page 1 »  
 
Submission author:
Assignment title:
Submission title:
File name:
File size:
Page count:
Word count:
Character count:
Submission date:
Submission ID:
Digital Receipt
This receipt acknowledges that Turnitin received your paper. Below you will find the receipt information
regarding your submission.
The first page of your submissions is displayed below.
221214004.ms Ent VELAVAN R V S
TNMGRMU EXAMINATIONS
“EFFECT OF DELIBERATE INGEST…
plagiarism_3_edited.docx
9.61M
100
10,809
61,925
22-Sep-2014 02:11AM
454423574
Copyright 2014 Turnitin. All rights reserved.
 
